NFKB1 and diffuse large B-cell lymphoma: Many factors, including persistent infections, the pro-inflammatory TME, immune receptors turned against auto-antigens, and mutations that alter the functions of key signaling effectors, may promote constitutive NF-κB activity in DLBCL [204].